News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
NIH Won’t Use Industry Money for Opioid Research Initiative
Shawna Williams | Apr 19, 2018
The announcement comes after an agency working group recommends against an industry partnership on ethical grounds.
Sanofi and Celgene Spend $20 Billion in Major Biotech Acquisitions
Katarina Zimmer | Jan 23, 2018
Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.
Dengue Vaccine Program Halted Over Safety Issues
Shawna Williams | Dec 5, 2017
The drug may worsen future infections for people who haven't already been exposed to the virus.
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
Diana Kwon | Dec 4, 2017
The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.
Takeda to Buy Cancer Drug Maker Ariad for $5.2 Billion
Joshua A. Krisch | Jan 10, 2017
The pharma giant’s purchase of the US firm includes the acquisition of investigative cancer drugs.
TS Picks: August 9, 2016
Bob Grant | Aug 9, 2016
Gene therapy money-back guarantee; the brain benefits from bilingualism; Q&A with a science watchdog
Pfizer Scoops Anacor for $5.3 Billion
Bob Grant | May 18, 2016
The acquisition-hungry pharmaceutical firm is purchasing the California-based eczema gel maker.
Bayer Enters CRISPR Field
Karen Zusi | Dec 22, 2015
The pharmaceutical company will spend $335 million on a new venture with biotech startup CRISPR Therapeutics.
Pfizer and Allergan to Merge
Bob Grant | Nov 23, 2015
The two drugmakers will join forces in a $160 billion deal—if it’s given the regulatory green light.
Shire Buys Rare Disease Drug Developer
Tracy Vence | Nov 2, 2015
The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.